DLGAP5 and non-small cell lung carcinoma: Among them, DLGAP5 could physically interact with PBK, TOP2A, and CDK1, and all mitosis-associated proteins correlated with poor prognosis for non-small cell lung cancer patients (Shih et al., 2012; Schneider et al., 2017).